2020 - Member of Academia Europaea
Peter Aaby focuses on Pediatrics, Immunology, Vaccination, Measles and Measles vaccine. His Pediatrics research includes elements of Epidemiology, Mortality rate, Randomized controlled trial, Child mortality and Infant mortality. His research integrates issues of Internal medicine, Incidence, Cohort study and Tuberculosis in his study of Immunology.
Peter Aaby has researched Vaccination in several fields, including Tuberculosis vaccines, Heterologous and Immunization. His Measles research includes elements of Viral disease, Case fatality rate, Vaccine efficacy and Serology. Peter Aaby usually deals with Measles vaccine and limits it to topics linked to Standardized mortality ratio and Cause of death.
His primary scientific interests are in Pediatrics, Vaccination, Immunology, Measles and Measles vaccine. The various areas that Peter Aaby examines in his Pediatrics study include Epidemiology, Mortality rate, Randomized controlled trial, Child mortality and Infant mortality. His work in the fields of BCG vaccine, Tetanus and Diphtheria overlaps with other areas such as Guinea bissau.
His Immunology research is multidisciplinary, incorporating perspectives in Internal medicine, Incidence, Cohort study and Tuberculosis. His study in Measles is interdisciplinary in nature, drawing from both Viral disease, Case fatality rate and Vaccine efficacy. His Measles vaccine research is multidisciplinary, relying on both Poliomyelitis, Standardized mortality ratio and Hazard ratio.
Peter Aaby mostly deals with Vaccination, Pediatrics, Measles vaccine, Measles and Mortality rate. His Vaccination study incorporates themes from Internal medicine, Randomized controlled trial, Proportional hazards model and Tuberculosis. His Pediatrics study combines topics in areas such as Lower mortality, Diphtheria, Tetanus, Public health and Prospective cohort study.
His Measles vaccine research integrates issues from Diphtheria tetanus pertussis, Poliomyelitis and Child mortality. His work deals with themes such as Psychological intervention, Attenuated vaccine and Clinical trial, which intersect with Measles. His BCG vaccine research is classified as research in Immunology.
Peter Aaby focuses on Vaccination, Randomized controlled trial, Measles, Tuberculosis and Pediatrics. His Vaccination research is under the purview of Immunology. His Randomized controlled trial research is multidisciplinary, incorporating elements of Odds ratio and Confidence interval.
His study in Measles focuses on Measles vaccine in particular. As a member of one scientific family, he mostly works in the field of Tuberculosis, focusing on Observational study and, on occasion, Rabies, Intensive care medicine and Clinical trial. His research ties Public health and Pediatrics together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Danish National Birth Cohort - its background, structure and aim:
Jørn Olsen;Mads Melbye;Sjurdur Frodi Olsen;Thorkild I.A. Sørensen.
Scandinavian Journal of Public Health (2001)
Measles and atopy in Guinea-Bissau
S.O Shaheen;D.J.P Barker;C.B Heyes;A.W Shiell.
The Lancet (1996)
BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
Rob J.W. Arts;Simone J.C.F.M. Moorlag;Boris Novakovic;Yang Li.
Cell Host & Microbe (2018)
Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
Christian Wejse;Victor F. Gomes;Paulo Rabna;Per Gustafson.
American Journal of Respiratory and Critical Care Medicine (2009)
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
Chiea C Khor;Stephen J Chapman;Stephen J Chapman;Fredrik O Vannberg;Aisling Dunne.
Nature Genetics (2007)
Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa
Ines Kristensen;Peter Aaby;Henrik Jensen.
Newborns Develop a Th1-Type Immune Response to Mycobacterium bovis Bacillus Calmette-Guérin Vaccination
Arnaud Marchant;Tessa Goetghebuer;Martin O. Ota;Ingrid Wolfe.
Journal of Immunology (1999)
Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
Peter Aaby;Adam Roth;Adam Roth;Henrik Ravn;Bitiguida Mutna Napirna.
The Journal of Infectious Diseases (2011)
A small jab – a big effect: nonspecific immunomodulation by vaccines
Christine S. Benn;Mihai G. Netea;Liisa K. Selin;Peter Aaby.
Trends in Immunology (2013)
Influence of Mycobacterium bovis Bacillus Calmette-Guérin on Antibody and Cytokine Responses to Human Neonatal Vaccination
Martin O. C. Ota;Johan Vekemans;Susanna E. Schlegel-Haueter;Katherine Fielding.
Journal of Immunology (2002)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: